News | January 28, 2014

St. Jude Medical Implants World’s First Leadless Pacemaker

St. Jude Medical Nanostim Leadless Pacemaker EP Lab
January 28, 2014 — Prof. Richard Schilling implanted St. Jude Medical Inc.’s Nanostim retrievable leadless pacemaker at St. Bartholomew’s Hospital, London.
 
The Nanostim leadless pacemaker is designed to implant directly in the heart without visible surgical pocket, scar and insulated wires. Implanted via the femoral vein with a steerable catheter, the device is designed to be fully retrievable to enable repositioning throughout implantation and after if necessary.
 
Maureen McCleave, a 77-year-old from Chingford who suffered from persistent atrial fibrillation, became the first person in the U.K. to receive the Nanostim device. The procedure lasted eight minutes and McCleave is expected to recover fully.
 
The Nanostim leadless pacemaker is less than 10 percent the size of a conventional pacemaker. Lack of a surgical pocket and lead intends to improve patient comfort and can reduce complications, including device pocket-related infection and lead failure. The device is supported by the St. Jude Medical Merlin Programmer.
 
Initial results from the LEADLESS study, a prospective, single-arm, multicenter study evaluating patients with the Nanostim leadless pacemaker, demonstrated overall device performance comparable to conventional pacemakers. Total implant procedure times averaged 28 minutes. The device battery is expected to have an average lifespan of more than nine years at 100 percent pacing, or more than 13 years at 50 percent pacing.
 
More than 4 million people worldwide have an implanted pacemaker or other cardiac rhythm management device, and an additional 700,000 patients receive the devices each year.
 
The Nanostim leadless pacemaker has CE marking and is available in select European markets, and is not for sale in the United States.
 
For more information: www.sjm.com

Related Content

Abbott Secures FDA Approval for MRI Compatibility on Ellipse ICD
Technology | Implantable Cardioverter Defibrillator (ICD)| September 22, 2017
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Technavio Projects 9 Percent Global Growth for Electrophysiology Therapeutic Devices

Image courtesy of Technavio

News | EP Lab| September 11, 2017
September 11, 2017 — According to the latest market study released by Technavio, the global...
EMANATE Trial Shows Apixaban Lowers stroke in AF Patients Undergoing Cardioversion.
News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with at
CASTLE-AF Study shows Catheter Ablation of Atrial Fibrillation is First-Line Treatment for Heart Failure Patients. Biotronic Ilivia 7 ICD.

The CASTLE-AF Study shows catheter alation of AF can be used effectively to treat heart failure in patients with an implanted ICD.

News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Final results from the CASTLE-AF study show a 38 percent reduction in the composite of all-cause
Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices

Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices.

Feature | EP Lab| August 29, 2017 | Dave Fornell
August 29, 2017 — The U.S.
Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT)| August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Overlay Init